Evaluation of Pharmacist Impact on Patients Initiating Eculizumab for Atypical Hemolytic Uremic Syndrome in the Inpatient Setting
Ann Pharmacother
.
2023 Apr;57(4):506-507.
doi: 10.1177/10600280221113830.
Epub 2022 Jul 29.
Authors
Paul Christopher Parish
,
Donald C Moore
,
Megan Wayman
,
Justin Arnall
PMID:
35906797
DOI:
10.1177/10600280221113830
No abstract available
Publication types
Letter
MeSH terms
Antibodies, Monoclonal, Humanized / therapeutic use
Atypical Hemolytic Uremic Syndrome* / drug therapy
Humans
Inpatients*
Pharmacists
Substances
eculizumab
Antibodies, Monoclonal, Humanized